SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001355250-12-000054
Filing Date
2012-12-10
Accepted
2012-12-10 07:53:43
Documents
4
Period of Report
2012-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 reportasp_8k.htm 8-K 43819
2 regrights_ex4z1.htm EX-4.1 128578
3 purchaseagr_ex10z1.htm EX-10.1 186889
4 pressrelease_ex99z1.htm EX-99.1 10708
  Complete submission text file 0001355250-12-000054.txt   371306
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-52321 | Film No.: 121251557
SIC: 2834 Pharmaceutical Preparations